Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Improving Genetic Risk Scores for Cardiovascular Diseases

FY 2021-22

Summary
Coronary Artery Disease (CAD) is the leading cause of death worldwide despite the availability of extensive therapeutic and lifestyle interventions. Thus, producing a high societal and economic burden. Consequently, CAD warrants research into pre-emptive diagnosing and intervention. Over the past decade, extensive genetic studies have identified many genetic variants that are associated with CAD. It is now possible to use all of these genetic variants to determine an individual’s relative susceptibility and predisposition to CAD. Our research focuses on regrouping certain genetic variants together according to their association with specific metabolic processes. For example, partitioning genetic variants according to their association with cholesterol yields a cholesterol-focused variant subset and a subset free of cholesterol variants. Our research also investigates the relationship between risk factors for CAD and these genetic variants. We can then assess whether these smaller variant subsets lead to an improvement in our ability to accurately assess a patient’s risk for CAD. These results may also shed light on the causes of CAD and pave the way for novel therapeutic targets.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
481146
Name
Desrochers Justine
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Improving Genetic Risk Scores for Cardiovascular Diseases
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Coronary Artery Disease; Genetic Risk Score; Genome Wide Association Study; Low-Density Lipoprotein Cholesterol; Myocardial Infarction; Single Nucleotide Polymorphism
Abstract
<html> <head> </head> <body> <span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none"><font color="rgb(0, 0, 0)" face="Verdana, Arial, Helvetica, sans-serif" size="12.8px">Coronary Artery Disease (CAD) is the leading cause of death worldwide despite the availability of extensive therapeutic and lifestyle interventions. Thus, producing a high societal and economic burden. Consequently, CAD warrants research into pre-emptive diagnosing and intervention. Over the past decade, extensive genetic studies have identified many genetic variants that are associated with CAD. It is now possible to use all of these genetic variants to determine an individual&#8217;s relative susceptibility and predisposition to CAD. Our research focuses on regrouping certain genetic variants together according to their association with specific metabolic processes. For example, partitioning genetic variants according to their association with cholesterol yields a cholesterol-focused variant subset and a subset free of cholesterol variants. Our research also investigates the relationship between risk factors for CAD and these genetic variants. We can then assess whether these smaller variant subsets lead to an improvement in our ability to accurately assess a patient&#8217;s risk for CAD. These results may also shed light on the causes of CAD and pave the way for novel therapeutic targets.</font></span> </body> </html>
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Desrochers, Justine
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~